These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study. Fabris S, Scarciolla O, Morabito F, Cifarelli RA, Dininno C, Cutrona G, Matis S, Recchia AG, Gentile M, Ciceri G, Ferrarini M, Ciancio A, Mannarella C, Neri A, Fragasso A. Genes Chromosomes Cancer; 2011 Sep; 50(9):726-34. PubMed ID: 21638517 [Abstract] [Full Text] [Related]
3. Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukaemia. Coll-Mulet L, Santidrián AF, Cosialls AM, Iglesias-Serret D, de Frias M, Grau J, Menoyo A, González-Barca E, Pons G, Domingo A, Gil J. Br J Haematol; 2008 Sep; 142(5):793-801. PubMed ID: 18564355 [Abstract] [Full Text] [Related]
5. Translocations as a mechanism for homozygous deletion of 13q14 and loss of the ATM gene in a patient with B-cell chronic lymphocytic leukemia. Herholz H, Kern W, Schnittger S, Haferlach T, Dicker F, Haferlach C. Cancer Genet Cytogenet; 2007 Apr 01; 174(1):57-60. PubMed ID: 17350468 [Abstract] [Full Text] [Related]
10. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia. Durak B, Akay OM, Aslan V, Ozdemir M, Sahin F, Artan S, Gülbas Z. Cancer Genet Cytogenet; 2009 Jan 15; 188(2):65-9. PubMed ID: 19100507 [Abstract] [Full Text] [Related]
11. [The interphase fluorescence in situ hybridization (I-FISH) technique in patients with chronic lymphatic leukemia (CLL)]. Michalová K, Zemanová Z, Cmunt E, Karban J, Brezinová J, Sindelárová L, Kurková S, Kubcová S, Schwarz J. Cas Lek Cesk; 2000 Jun 07; 139(11):334-8. PubMed ID: 10953412 [Abstract] [Full Text] [Related]
12. Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia. Carter A, Lin K, Sherrington PD, Atherton M, Pearson K, Douglas A, Burford A, Brito-Babapulle V, Matutes E, Catovsky D, Pettitt AR. Leukemia; 2006 Apr 07; 20(4):737-40. PubMed ID: 16437137 [No Abstract] [Full Text] [Related]
16. [Prognostic significance of p53 and ATM gene deletion in patients with chronic lymphocytic leukemia]. Xu W, Li JY, Li L, Wu YJ, Yu H, Shen QD, Qiu HX. Zhonghua Xue Ye Xue Za Zhi; 2008 Jul 07; 29(7):450-3. PubMed ID: 19035176 [Abstract] [Full Text] [Related]
17. Increased transferrin receptor expression following 11q23 deletion as a mechanism of malignant progression in chronic lymphocytic leukemia. Shackelford RE, Bhalodia AR, Cotelingam JD, Veillon DM, Lowery-Nordberg M. Med Hypotheses; 2006 Jul 07; 66(3):509-12. PubMed ID: 16326028 [Abstract] [Full Text] [Related]
18. Detection of chromosomal abnormalities associated with chronic lymphocytic leukemia: what is the best method? El-Taweel M, Barin C, Cymbalista F, Eclache V. Cancer Genet Cytogenet; 2009 Nov 07; 195(1):37-42. PubMed ID: 19837267 [Abstract] [Full Text] [Related]
19. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. Ouillette P, Erba H, Kujawski L, Kaminski M, Shedden K, Malek SN. Cancer Res; 2008 Feb 15; 68(4):1012-21. PubMed ID: 18281475 [Abstract] [Full Text] [Related]
20. Contribution of MLPA to routine diagnostic testing of recurrent genomic aberrations in chronic lymphocytic leukemia. Véronèse L, Tournilhac O, Combes P, Prie N, Pierre-Eymard E, Guièze R, Veyrat-Masson R, Bay JO, Vago P, Tchirkov A. Cancer Genet; 2013 Feb 15; 206(1-2):19-25. PubMed ID: 23313109 [Abstract] [Full Text] [Related] Page: [Next] [New Search]